Company / Interest Expense per Share
Krystal Biotech, Inc. Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-
FY2023
5-year range
$0.00 / $0.07
FY2020-FY2023
Trend
-
vs FY2022
Sector context
#39 of 43
Health Care
What the data says
Improved from $0.07 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 43
▼
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.07 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026